Mosaic ImmunoEngineering (CPMV) Assets Average (2011 - 2026)
Mosaic ImmunoEngineering (CPMV) posted quarterly Assets Average of $14855.0 for Q1 2026, down 87.59% year-over-year from $119697.5 in Q1 2025, and down 60.48% quarter-over-quarter from $37590.0 in Q4 2025.
Mosaic ImmunoEngineering (CPMV) Assets Average (2011 - 2026) Analysis & Trends
Mosaic ImmunoEngineering's Assets Average history runs 16 years deep, the most recent figure standing at $14855.0 for Q1 2026.
- In Q1 2026, Assets Average fell 87.59% year-over-year to $14855.0; the TTM figure through Mar 2026 stood at $14855.0 (down 87.59% YoY), while the FY2025 annual figure was $80746.5, down 49.71% from the prior year.
- Assets Average for Q1 2026 stood at $14855.0, down from $37590.0 in the prior quarter.
- The five-year high for Assets Average was $347102.0 in Q4 2022, with the low at $14855.0 in Q1 2026.
- The 5-year median for Assets Average is $129242.5 (2024), against an average of $173350.1.
- The sharpest annual moves came in 2024 and 2025: Assets Average sank 92.03% in 2024, then jumped 116.36% in 2025.
- Mosaic ImmunoEngineering's Assets Average stood at $347102.0 in 2022, then tumbled by 33.01% to $232530.5 in 2023, then slumped by 60.96% to $90780.5 in 2024, then slumped by 58.59% to $37590.0 in 2025, then sank by 60.48% to $14855.0 in 2026.
- Business Quant data shows CPMV's Assets Average at $14855.0 in Q1 2026, $37590.0 in Q4 2025, and $56498.5 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 5.34 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 2.09 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.82 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 25.27 Bn |
| 10 | Mosaic ImmunoEngineering | 527,536.97 | 527,536.97 | - | 14,855.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14,855.00 |
| Dec 31, 2025 | 37,590.00 |
| Sep 30, 2025 | 56,498.50 |
| Jun 30, 2025 | 77,741.50 |
| Mar 31, 2025 | 119,697.50 |
| Dec 31, 2024 | 90,780.50 |
| Sep 30, 2024 | 26,113.50 |
| Jun 30, 2024 | 45,614.50 |
| Mar 31, 2024 | 129,242.50 |
| Dec 31, 2023 | 232,530.50 |
| Sep 30, 2023 | 327,445.50 |
| Jun 30, 2023 | 258,916.00 |
| Mar 31, 2023 | 204,873.00 |
| Dec 31, 2022 | 347,102.00 |
| Sep 30, 2022 | 328,039.00 |
| Jun 30, 2022 | 313,370.50 |
| Mar 31, 2022 | 336,542.00 |
| Dec 31, 2021 | 357,575.50 |
| Sep 30, 2021 | 523,993.00 |
| Jun 30, 2021 | 434,929.50 |